1 paper mentions it2 findings
See all 1 papers on adropin, asprosin, and irisin
“No statistically significant differences were found in serum adropin, irisin, and asprosin levels across diabetes status groups (p > 0.05).”
Effects
2Framingham risk score
no changein humans1
1 study
Framingham risk score
no changein humans1
Adropin, asprosin, and irisin was not clearly linked with Framingham risk score in humans (healthy, prediabetic, and T2DM individuals).
“While no direct significant relationship was observed between these biomarkers and FRS”
Humanshealthy, prediabetic, and T2DM individuals
Scientific reports
Diabetes status
no changein humans1
1 study
Diabetes status
no changein humans1
Adropin, asprosin, and irisin was not clearly linked with diabetes status in humans (healthy, prediabetic, and T2DM individuals) (p > 0.05).
“No statistically significant differences were found in serum adropin, irisin, and asprosin levels across diabetes status groups (p > 0.05).”
Humanshealthy, prediabetic, and T2DM individualsserum
Scientific reports
Latest
1 paper in 12 monthsScientific Reports
Beyond glycemia: adropin, asprosin, and irisin as potential biomarkers for cardiovascular risk in diabetes and prediabetes
Case-control study of 30 peopleIrisin